3185 results for «2147»
3185 results
Taking the next step in the evolution of aortic regurgitation treatment
31 Jan 2025 – From PCR Imaging Valves Madrid 2025
Explore the latest in aortic regurgitation treatment, including a TAVI case with the Trilogy device, imaging challenges, and future advancements like CMR and guideline updates.
Advancing transcatheter solutions for tricuspid valve disease
01 Feb 2025 – From PCR Imaging Valves Madrid 2025
This session delves into the latest advancements in transcatheter tricuspid valve interventions, covering procedural considerations, patient selection, and imaging techniques. Explore case studies, strategies for tricuspid transcatheter edge-to-edge repair, and key criteria for valve replacement. Learn about managing failed T-TEER cases and the role of transcatheter...
Optimizing diagnosis and treatment in multivalvular heart disease
01 Feb 2025 – From PCR Imaging Valves Madrid 2025
This session explores the diagnostic challenges and treatment strategies for mixed and multiple valvular heart diseases. Through case scenarios, including aortic stenosis, regurgitation, and combined atrioventricular valve regurgitation, learn how to use imaging modalities to assess severity and determine optimal treatment timing.
Left main bifurcation instent restenosis - LIVE case
18 Dec 2024 – From GulfPCR-GIM 2024
A 76-year-old male with a history of LM PCI (2-stent strategy), RCA PCI, reduced LV function (25%), diabetes, and CKD presented with worsening angina. Angiography revealed in-stent restenosis at the ostium of the LAD and CX, along with RCA occlusion.
The procedure was performed with axillary Impella...
The five most impactful trials of 2024
19 Dec 2024 – From GulfPCR-GIM 2024
Stay ahead of the curve by exploring the five most impactful cardiovascular intervention trials of 2024. Gain insights into the latest evidence that can transform your clinical practice. Analyze the methodology and applicability of these groundbreaking studies, and learn how to seamlessly integrate them into your...
